• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰弱前期慢性阻塞性肺疾病患者的住院和死亡预后取决于其身体功能表现水平。

The prognosis of pre-frail chronic obstructive pulmonary disease patients for hospitalizations and mortality depends on their level of functional physical performance.

机构信息

Department of Physical Therapy, 16751University of Murcia, Murcia, Spain.

Research Group Fisioterapia y Discapacidad, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.

出版信息

Chron Respir Dis. 2022 Jan-Dec;19:14799731221119810. doi: 10.1177/14799731221119810.

DOI:10.1177/14799731221119810
PMID:36071021
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9459488/
Abstract

OBJECTIVE

To determine if pre-frail Chronic obstructive pulmonary disease (COPD) patients with poor and non-poor performance in the five-repetition sit-to-stand test (5-STS) had a worse prognosis for hospitalization and mortality at 2 years and for mortality at 5 years than non-frail patients.

METHODS

We prospectively included patients with stable COPD, between 40 and 80 years, from a hospital in Spain. Patients were classified according their performance on the 5-STS test and level of frailty. Timing, number of hospitalizations, length of stay, and timing and rate of mortality were outcome measures. Patients were followed for 2 years for exacerbations and for 5 years for mortality. Kaplan-Meier curves and univariate and multivariate Cox proportional-hazard analyses, ANOVA tests and univariate and multivariate linear and logistic regression models were used.

RESULTS

Of the 125 patients included, 25.6% were pre-frail with poor performance, 57% pre-frail with non-poor performance, and 17.4% non-frail with non-poor performance. Pre-frail patients with poor performance had a higher number of hospitalizations (adjusted beta: 0.49; 95% CI: 0.01-0.96), mortality rates (odds ratio: 11.33; 95% CI: 1.15-110.81), and risk at 5 years (adjusted hazard ratio: 8.77; 95% CI: 1.02-75.51) than non-frail patients. Pre-frail patients with poor performance also had worse prognoses than non-frail patients with respect to length of hospital stays (increased by 4.16 days) and timing to first hospitalization (HR: 6.01) in unadjusted models, but not when adjusted.

CONCLUSION

The COPD prognosis of pre-frail patients with respect to the number of exacerbations with hospitalization and the timing and rate of mortality is dependent of functional performance.

摘要

目的

确定在五次重复坐立试验(5-STS)中表现差和非差的衰弱前期慢性阻塞性肺疾病(COPD)患者与非衰弱患者相比,2 年时住院和死亡率以及 5 年时死亡率的预后是否更差。

方法

我们前瞻性纳入了来自西班牙一家医院的 40 至 80 岁稳定期 COPD 患者。根据 5-STS 测试和虚弱程度对患者进行分类。观察终点为住院时间、住院次数、住院时间、死亡时间和死亡率。患者随访 2 年以观察加重情况,随访 5 年以观察死亡情况。采用 Kaplan-Meier 曲线和单因素及多因素 Cox 比例风险分析、方差分析和单因素及多因素线性和逻辑回归模型。

结果

在纳入的 125 名患者中,25.6%为衰弱前期且表现差,57%为衰弱前期且表现非差,17.4%为非衰弱且表现非差。表现差的衰弱前期患者住院次数更多(调整后β:0.49;95%CI:0.01-0.96)、死亡率更高(优势比:11.33;95%CI:1.15-110.81)、5 年风险更高(调整后危险比:8.77;95%CI:1.02-75.51),而非衰弱前期患者。在未调整模型中,与非衰弱前期患者相比,表现差的衰弱前期患者的住院时间(增加 4.16 天)和首次住院时间(HR:6.01)也较差,但在调整后模型中则不然。

结论

衰弱前期 COPD 患者的住院和死亡率随时间变化的预后取决于功能表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af82/9459488/e474fca21835/10.1177_14799731221119810-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af82/9459488/4b7771c6c3b5/10.1177_14799731221119810-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af82/9459488/e474fca21835/10.1177_14799731221119810-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af82/9459488/4b7771c6c3b5/10.1177_14799731221119810-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af82/9459488/e474fca21835/10.1177_14799731221119810-fig2.jpg

相似文献

1
The prognosis of pre-frail chronic obstructive pulmonary disease patients for hospitalizations and mortality depends on their level of functional physical performance.衰弱前期慢性阻塞性肺疾病患者的住院和死亡预后取决于其身体功能表现水平。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221119810. doi: 10.1177/14799731221119810.
2
Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations.慢性阻塞性肺疾病中的衰弱及其与加重和住院风险的关系。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 11;15:1967-1976. doi: 10.2147/COPD.S245505. eCollection 2020.
3
Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?衰弱与慢性阻塞性肺疾病恶化:二者有关联吗?
Int J Chron Obstruct Pulmon Dis. 2024 May 24;19:1131-1139. doi: 10.2147/COPD.S455316. eCollection 2024.
4
Five-Repetition Sit-to-Stand Test as Predictor of Mortality in High Risk COPD Patients.五次重复坐立试验作为高危慢性阻塞性肺疾病患者死亡率的预测指标
Arch Bronconeumol. 2025 Feb;61(2):90-95. doi: 10.1016/j.arbres.2024.07.026. Epub 2024 Aug 31.
5
Frailty and Clinical Outcomes in Chronic Obstructive Pulmonary Disease.衰弱与慢性阻塞性肺疾病的临床结局。
Ann Am Thorac Soc. 2019 Feb;16(2):217-224. doi: 10.1513/AnnalsATS.201803-175OC.
6
Impact of Frailty on the Risk of Exacerbations and All-Cause Mortality in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease.衰弱对老年稳定期慢性阻塞性肺疾病患者加重风险和全因死亡率的影响。
Clin Interv Aging. 2021 Apr 13;16:593-601. doi: 10.2147/CIA.S303852. eCollection 2021.
7
Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?衰弱是慢性阻塞性肺疾病患者的死亡预测因子吗?
Int J Chron Obstruct Pulmon Dis. 2023 Dec 11;18:2955-2960. doi: 10.2147/COPD.S439966. eCollection 2023.
8
Upper-extremity function prospectively predicts adverse discharge and all-cause COPD readmissions: a pilot study.上肢功能可前瞻性预测不良出院情况及慢性阻塞性肺疾病(COPD)的全因再入院:一项试点研究。
Int J Chron Obstruct Pulmon Dis. 2018 Dec 18;14:39-49. doi: 10.2147/COPD.S182802. eCollection 2019.
9
Mortality Risks after Two Years in Frail and Pre-Frail Older Adults Admitted to Hospital.住院的体弱及准体弱老年人两年后的死亡风险
J Clin Med. 2023 Apr 24;12(9):3103. doi: 10.3390/jcm12093103.
10
Association of Frailty with Patient-Report Outcomes and Major Clinical Determinants in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.衰弱与慢性阻塞性肺疾病急性加重患者的患者报告结局和主要临床指标的相关性。
Int J Chron Obstruct Pulmon Dis. 2024 Apr 12;19:907-919. doi: 10.2147/COPD.S444580. eCollection 2024.

引用本文的文献

1
Longitudinal transitions in frailty and health-related quality of life investigated by a 5-year community study.一项为期5年的社区研究对衰弱和健康相关生活质量的纵向转变进行了调查。
Sci Rep. 2025 Apr 30;15(1):15162. doi: 10.1038/s41598-025-99843-7.

本文引用的文献

1
Quadriceps physiological response during the 1-min sit-to-stand test in people with severe COPD and healthy controls.严重 COPD 患者和健康对照者在 1 分钟坐站测试中股四头肌的生理反应。
Sci Rep. 2022 Jan 17;12(1):794. doi: 10.1038/s41598-022-04820-z.
2
Frailty Assessment in a Stable COPD Cohort: Is There a COPD-Frail Phenotype?稳定期 COPD 队列中的衰弱评估:是否存在 COPD 衰弱表型?
COPD. 2021 Oct;18(5):525-532. doi: 10.1080/15412555.2021.1975670. Epub 2021 Sep 9.
3
Toward Remote Assessment of Physical Frailty Using Sensor-based Sit-to-stand Test.
基于传感器的坐站测试实现身体虚弱的远程评估。
J Surg Res. 2021 Jul;263:130-139. doi: 10.1016/j.jss.2021.01.023. Epub 2021 Feb 27.
4
The five-repetition sit-to-stand test is a predictive factor of severe exacerbations in COPD.五次重复坐立试验是慢性阻塞性肺疾病严重急性加重的一个预测因素。
Ther Adv Chronic Dis. 2021 Jan 22;12:2040622320986718. doi: 10.1177/2040622320986718. eCollection 2021.
5
The Correlation of Sit-to-Stand Tests with COPD Assessment Test and GOLD Staging Classification.坐姿到站起测试与 COPD 评估测试和 GOLD 分期分类的相关性。
COPD. 2020 Dec;17(6):655-661. doi: 10.1080/15412555.2020.1825661. Epub 2020 Oct 6.
6
Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients.慢性阻塞性肺疾病患者衰弱的患病率及相关变量评估
Int J Chron Obstruct Pulmon Dis. 2020 Jun 12;15:1349-1356. doi: 10.2147/COPD.S250299. eCollection 2020.
7
Prognostic value of simple measures of physical function and muscle strength in COPD: A systematic review.简单的身体功能和肌肉力量测量指标在 COPD 中的预后价值:系统评价。
Respir Med. 2020 Jan;161:105856. doi: 10.1016/j.rmed.2019.105856. Epub 2019 Dec 19.
8
[Structure and metric properties of a questionnaire to measure disability in mobility activities in patients with chronic obstructive pulmonary disease (DIAMO-COPD questionnaire)].
Rehabilitacion (Madr). 2019 Oct-Dec;53(4):232-239. doi: 10.1016/j.rh.2019.07.001. Epub 2019 Oct 16.
9
Reliability and usability of a weighted version of the Functional Comorbidity Index.功能合并症指数加权版本的可靠性和可用性。
Clin Interv Aging. 2019 Feb 11;14:289-299. doi: 10.2147/CIA.S185112. eCollection 2019.
10
Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.COPD 中的生物标志物和临床结局:系统评价和荟萃分析。
Thorax. 2019 May;74(5):439-446. doi: 10.1136/thoraxjnl-2018-211855. Epub 2019 Jan 7.